Esomeprazole Magnesium Hydrate

埃索美拉唑镁

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameEsomeprazole Magnesium Hydrate
Drug Alias NameNexium I.V.埃索美拉唑镁水合物Perprazole(esomeprazole)埃索美拉唑镁三水合物艾司奥美拉唑镁 +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsHelicobacter pylori infectionHeartburnDyspepsia +[11] 
Global Approved IndicationsHelicobacter pylori infectionDyspepsiaStomach Ulcer +[9] 
Approved Indications in ChinaStomach UlcerGastroesophageal Reflux
Original Approved Country/TerritorySweden
Original Approved Date2000/03/13
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesGenuine Research Center, EgyptBio-innova Co LtdHaleon PLC +[10] 
Inactive CompaniesHanmi Pharmaceutical Co LtdTorrent Pharmaceuticals LtdTakeda Pharmaceutical Co Ltd +[5] 
Active IndicationsHelicobacter pylori infectionHeartburnDyspepsia +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BC05
Related LinksWikipediaDrugBankKEGG